HeXun Biosciences , Ltd. Overview
Get informed when a big investor buys or sells
+ Follow17.18
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
HeXun Biosciences , Ltd. (6986.TWO) currently reports a P/E ratio of 17.18. That is below the Healthcare sector average of 70.94. Use the charts on this page to explore HeXun Biosciences , Ltd.'s P/E ratio history and peer comparisons.
HeXun Biosciences , Ltd.'s P/E ratio of 17.18 is lower than the Healthcare sector average of 70.94. That is roughly 75.8% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
The P/E ratio is a valuation multiple that relates HeXun Biosciences , Ltd.'s market price to a fundamental measure such as earnings, sales, or book value. At 17.18, 6986.TWO can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.
Start with the current P/E ratio of 17.18, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 70.94. From there, open related valuation or income-statement pages for HeXun Biosciences , Ltd., and consider following 6986.TWO for alerts when major investors trade the stock.
HeXun Biosciences , Ltd. is classified in the Healthcare sector. On P/E ratio, it currently shows 17.18 versus a sector average near 70.94. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing 6986.TWO with unrelated industries.
